Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Innodata Inc (INOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Innodata Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Innodata Inc trades at $62.18 (market cap $2.18B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.2× Innodata Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Innodata Inc for 19 Days on average.
| DFTX | INOD | |
|---|---|---|
Market Cap | $4.71B | $2.18B |
Volume | 1,966,636 | 1,415,262 |
Sector | Health | Technology |
52-Week High | $48.45 | $121.50 |
52-Week Low | $10.68 | $34.45 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $3.67B | $1.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INOD trades at $63.42, down 4.26% today, but maintains strong technical support near $63. The company demonstrates robust fundamentals with revenue growing from $252M in 2025 to $317M in 2026 and net income expanding from $32M to $46M. Recent quarterly earnings consistently beat expectations, with Q1 2026 EPS of $0.42 surpassing the $0.13 estimate. Analyst sentiment remains positive with a 66.7% buy rating consensus.
INOD presents growth potential through its AI data engineering services and new motion-capture lab expansion, though premium valuation metrics (P/E 49.12, P/S 6.91) and customer concentration risks warrant caution. The stock's technical positioning near key support levels combined with strong earnings momentum supports a constructive outlook for investors seeking AI infrastructure exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →
